These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 29093266)

  • 1. Macrophage-derived oncostatin M contributes to human and mouse neurogenic heterotopic ossifications.
    Torossian F; Guerton B; Anginot A; Alexander KA; Desterke C; Soave S; Tseng HW; Arouche N; Boutin L; Kulina I; Salga M; Jose B; Pettit AR; Clay D; Rochet N; Vlachos E; Genet G; Debaud C; Denormandie P; Genet F; Sims NA; Banzet S; Levesque JP; Lataillade JJ; Le Bousse-Kerdilès MC
    JCI Insight; 2017 Nov; 2(21):. PubMed ID: 29093266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncostatin M: Dual Regulator of the Skeletal and Hematopoietic Systems.
    Sims NA; Lévesque JP
    Curr Osteoporos Rep; 2024 Feb; 22(1):80-95. PubMed ID: 38198032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of JAK1/2 Tyrosine Kinases Reduces Neurogenic Heterotopic Ossification After Spinal Cord Injury.
    Alexander KA; Tseng HW; Fleming W; Jose B; Salga M; Kulina I; Millard SM; Pettit AR; Genêt F; Levesque JP
    Front Immunol; 2019; 10():377. PubMed ID: 30899259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurogenic Heterotopic Ossifications Recapitulate Hematopoietic Stem Cell Niche Development Within an Adult Osteogenic Muscle Environment.
    Girard D; Torossian F; Oberlin E; Alexander KA; Gueguen J; Tseng HW; Genêt F; Lataillade JJ; Salga M; Levesque JP; Le Bousse-Kerdilès MC; Banzet S
    Front Cell Dev Biol; 2021; 9():611842. PubMed ID: 33748104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurogenic Heterotopic Ossifications Develop Independently of Granulocyte Colony-Stimulating Factor and Neutrophils.
    Tseng HW; Kulina I; Salga M; Fleming W; Vaquette C; Genêt F; Levesque JP; Alexander KA
    J Bone Miner Res; 2020 Nov; 35(11):2242-2251. PubMed ID: 32568412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1 Is Overexpressed in Injured Muscles Following Spinal Cord Injury and Promotes Neurogenic Heterotopic Ossification.
    Tseng HW; Kulina I; Girard D; Gueguen J; Vaquette C; Salga M; Fleming W; Jose B; Millard SM; Pettit AR; Schroder K; Thomas G; Wheeler L; Genêt F; Banzet S; Alexander KA; Lévesque JP
    J Bone Miner Res; 2022 Mar; 37(3):531-546. PubMed ID: 34841579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological heterotopic ossification following spinal cord injury is triggered by macrophage-mediated inflammation in muscle.
    Genêt F; Kulina I; Vaquette C; Torossian F; Millard S; Pettit AR; Sims NA; Anginot A; Guerton B; Winkler IG; Barbier V; Lataillade JJ; Le Bousse-Kerdilès MC; Hutmacher DW; Levesque JP
    J Pathol; 2015 Jun; 236(2):229-40. PubMed ID: 25712044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncostatin M regulates hematopoietic stem cell (HSC) niches in the bone marrow to restrict HSC mobilization.
    Bisht K; McGirr C; Lee SY; Tseng HW; Fleming W; Alexander KA; Matsumoto T; Barbier V; Sims NA; Müller-Newen G; Winkler IG; Bonig H; Lévesque JP
    Leukemia; 2022 Feb; 36(2):333-347. PubMed ID: 34518644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin M signaling.
    Guihard P; Danger Y; Brounais B; David E; Brion R; Delecrin J; Richards CD; Chevalier S; Rédini F; Heymann D; Gascan H; Blanchard F
    Stem Cells; 2012 Apr; 30(4):762-72. PubMed ID: 22267310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncostatin m, an inflammatory cytokine produced by macrophages, supports intramembranous bone healing in a mouse model of tibia injury.
    Guihard P; Boutet MA; Brounais-Le Royer B; Gamblin AL; Amiaud J; Renaud A; Berreur M; Rédini F; Heymann D; Layrolle P; Blanchard F
    Am J Pathol; 2015 Mar; 185(3):765-75. PubMed ID: 25559270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncostatin M maintains the hematopoietic microenvironment in the bone marrow by modulating adipogenesis and osteogenesis.
    Sato F; Miyaoka Y; Miyajima A; Tanaka M
    PLoS One; 2014; 9(12):e116209. PubMed ID: 25551451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine Oncostatin M Has Opposing Effects on the Proliferation of OP9 Bone Marrow Stromal Cells and NIH/3T3 Fibroblasts Signaling through the OSMR.
    Jakob L; Müller TA; Rassner M; Kleinfelder H; Veratti P; Mitschke J; Miething C; Oostendorp RAJ; Pfeifer D; Waterhouse M; Duyster J
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When the Nervous System Turns Skeletal Muscles into Bones: How to Solve the Conundrum of Neurogenic Heterotopic Ossification.
    Alexander KA; Tseng HW; Salga M; Genêt F; Levesque JP
    Curr Osteoporos Rep; 2020 Dec; 18(6):666-676. PubMed ID: 33085000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA Profiling of Mouse Ependymal Cells after Spinal Cord Injury Identifies the Oncostatin Pathway as a Potential Key Regulator of Spinal Cord Stem Cell Fate.
    Chevreau R; Ghazale H; Ripoll C; Chalfouh C; Delarue Q; Hemonnot-Girard AL; Mamaeva D; Hirbec H; Rothhut B; Wahane S; Perrin FE; Noristani HN; Guerout N; Hugnot JP
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncostatin m regulates mesenchymal cell differentiation and enhances hematopoietic supportive activity of bone marrow stromal cell lines.
    Yanai N; Obinata M
    In Vitro Cell Dev Biol Anim; 2001; 37(10):698-704. PubMed ID: 11776976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted disruption of oncostatin M receptor results in altered hematopoiesis.
    Tanaka M; Hirabayashi Y; Sekiguchi T; Inoue T; Katsuki M; Miyajima A
    Blood; 2003 Nov; 102(9):3154-62. PubMed ID: 12855584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncostatin M regulates SOCS3 mRNA stability via the MEK-ERK1/2-pathway independent of p38(MAPK)/MK2.
    Ehlting C; Böhmer O; Hahnel MJ; Thomas M; Zanger UM; Gaestel M; Knoefel WT; Schulte Am Esch J; Häussinger D; Bode JG
    Cell Signal; 2015 Mar; 27(3):555-67. PubMed ID: 25562430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Bone and Muscle Injuries on the Osteogenic Potential of Muscle Progenitors: Contribution of Tissue Environment to Heterotopic Ossification.
    Molligan J; Mitchell R; Schon L; Achilefu S; Zahoor T; Cho Y; Loube J; Zhang Z
    Stem Cells Transl Med; 2016 Jun; 5(6):745-53. PubMed ID: 27112178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncostatin M regulates neural precursor activity in the adult brain.
    Beatus P; Jhaveri DJ; Walker TL; Lucas PG; Rietze RL; Cooper HM; Morikawa Y; Bartlett PF
    Dev Neurobiol; 2011 Jul; 71(7):619-33. PubMed ID: 21671408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncostatin M-mediated regulation of KIT-ligand-induced extracellular signal-regulated kinase signaling maintains hematopoietic repopulating activity of Lin-CD34+CD133+ cord blood cells.
    Oostendorp RA; Gilfillan S; Parmar A; Schiemann M; Marz S; Niemeyer M; Schill S; Hammerschmid E; Jacobs VR; Peschel C; Götze KS
    Stem Cells; 2008 Aug; 26(8):2164-72. PubMed ID: 18499891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.